New Hodgkin's Protocol: Brentuximab Vedotin and NivolumabNew Hodgkin's Protocol: Brentuximab Vedotin and Nivolumab

The new treatment protocol may advance the goal of phasing out the use of nonspecific, cytotoxic chemotherapy as a treatment for this disease. Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news